Targetable cellular signaling events mediate vascular pathology in vascular Ehlers-Danlos syndrome
Open Access
- 17 December 2019
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (2) , 686-698
Abstract
Vascular Ehlers-Danlos syndrome (vEDS) is an autosomal-dominant connective tissue disorder caused by heterozygous mutations in the COL3A1 gene, which encodes the pro-alpha 1 chain of collagen III. Loss of structural integrity of the extracellular matrix is believed to drive the signs and symptoms of this condition, including spontaneous arterial dissection and/or rupture, the major cause of mortality. We created two mouse models of vEDS that carry heterozygous mutations in Col3a1 that encode glycine substitutions analogous to those found in patients, and showed that signaling abnormalities in the PLC/IP3/PKC/ERK pathway (phospholipase C/inositol 1,4,5-triphosphate/protein kinase C/extracellular signal-regulated kinase) are major mediators of vascular pathology.Treatment with pharmacologic inhibitors of ERK1/2 or PKC-beta prevented death due to spontaneous aortic rupture. Additionally, we found that pregnancy- and puberty-associated accentuation of vascular risk, also seen in vEDS patients, is rescued by attenuation of oxytocin and androgen signaling, respectively. Taken together, our results provide evidence that targetable signaling abnormalities contribute to the pathogenesis of vEDS, highlighting unanticipated therapeutic opportunities.Keywords
All Related Versions
Funding Information
- National Institutes of Health (AR41135)
- National Institutes of Health (GM007309)
- Howard Hughes Medical Institute (N/A)
- National Marfan Foundation (2-year Faculty Grant)
- Ehlers Danlos Syndrome Network C.A.R.E.S. Foundation (N/A)
- EDS Today (N/A)
- Daskal Family Foundation (N/A)
- Alison Aldredge Family Foundation (N/A)
- DEFY Foundation (N/A)
- Natural Sciences and Engineering Research Council of Canada (N/A)
- Fulbright Chile (Fulbright-Conicyt Scholarship)
- FONDECYT Grant (11170353)
This publication has 64 references indexed in Scilit:
- EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experimentsBioinformatics, 2013
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- Bicuspid Aortic Valve Disease and Ascending Aortic Aneurysms: Gaps in KnowledgeCardiology Research and Practice, 2012
- Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential TherapeuticsJournal of Neuroendocrinology, 2012
- Doxycycline Ameliorates the Susceptibility to Aortic Lesions in a Mouse Model for the Vascular Type of Ehlers-Danlos SyndromeThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Angiotensin II Type 2 Receptor Signaling Attenuates Aortic Aneurysm in Mice Through ERK AntagonismScience, 2011
- Noncanonical TGFβ Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome MiceScience, 2011
- Haploinsufficiency of the murine Col3a1 locus causes aortic dissection: a novel model of the vascular type of Ehlers–Danlos syndromeCardiovascular Research, 2010
- Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE−/− miceClinical Science, 2010
- Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan SyndromeScience, 2006